Sovleplenib
7-[4-(1-methylsulfonylpiperidin-4-yl)phenyl]-N-[[(2S)-morpholin-2-yl]methyl]pyrido[3,4-b]pyrazin-5-amine
Molecular Identity
Sovleplenib
7-[4-(1-methylsulfonylpiperidin-4-yl)phenyl]-N-[[(2S)-morpholin-2-yl]methyl]pyrido[3,4-b]pyrazin-5-amine
PubChem CID: 71113742
2D Structure
Properties
C24H30N6O3S
Molecular Formula
482.60
Molecular Weight
g/mol
482.2100
Exact Mass
Da
1.2
XLogP
Drug-like (Lipinski: < 5)
118
TPSA
Good oral absorption (< 140 A²)
2
H-Bond Donors
9
H-Bond Acceptors
748
Complexity
SMILES
Canonical SMILES
SMILES: CS(=O)(=O)N1CCC(CC1)C2=CC=C(C=C2)C3=CC4=NC=CN=C4C(=N3)NCC5CNCCO5Isomeric SMILES
SMILES: CS(=O)(=O)N1CCC(CC1)C2=CC=C(C=C2)C3=CC4=NC=CN=C4C(=N3)NC[C@@H]5CNCCO5Synonyms(20)
Sovleplenib1415792-84-5HMPL-523Sovleplenib [INN]9CL6353KHOHMPL523compound 225 [WO2012167733A1](S)-7-(4-(1-(Methylsulfonyl)piperidin-4-yl)phenyl)-N-(morpholin-2-ylmethyl)pyrido(4,3-b)pyrazin-5-aminecompound 225 (WO2012167733A1)RefChem:184501Syk Inhibitor HMPL-523HMPL-523 [WHO-DD]Spleen Tyrosine Kinase Inhibitor HMPL-523Hmpl 523(S)-7-(4-(1-(METHYLSULFONYL)PIPERIDIN-4-YL)PHENYL)-N-(MORPHOLIN-2-YLMETHYL)PYRIDO[3,4-B]PYRAZIN-5-AMINE
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Sovleplenib
Loading drug network...